tbuckley/cabot-search huggingface dataset:
Methylation Profiling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma
Authors: Franziska C. Eberle, Jaime Rodriguez-Canales, Lai Wei, Jeffrey C. Hanson, J. Keith Killian, Hong-Wei Sun, Lisa G. Adams, Stephen M. Hewitt, Wyndham H. Wilson, Paul S. Meltzer, Louis M. Staudt, Michael R. Emmert-Buck, Stefania Pittaluga, Elaine S. Jaffe
Journal: Blood (2010)
Comorbid Diabetes Does Not Impact the Survival of Patients with Multiple Myeloma
Authors: Liang-Tsai Hsiao, Tzeon-Jye Chiou, Ying-Chung Hong, Chun-Yu Liu, Yuan-Bin Yu, Hao-Wei Teng, Sheng-Hsiang Yang, Ching-Fen Yang, Jyh-Pyng Gau, Jin-Hwang Liu, Hui-Chi Hsu, Po-Min Chen, Cheng-Hwai Tzeng
Journal: Blood (2010)
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Authors: Stefanie Fischer, Torgrim Tandstad, Matthew Wheater, Emilio Porfiri, Aude Fléchon, Jorge Aparicio, Dirk Klingbiel, Breda Skrbinc, Umberto Basso, Jonathan Shamash, Anja Lorch, Klaus-Peter Dieckmann, Gabriella Cohn-Cedermark, Olof Ståhl, Caroline Chau, Edurne Arriola, Kalena Marti, Paul Hutton, Brigitte Laguerre, Pablo Maroto, Jörg Beyer, Silke Gillessen
Journal: Journal of Clinical Oncology (2017)

Purpose Adjuvant carboplatin is one of three management strategies that may follow inguinal orchiectomy in clinical stage I seminoma. However, little is known about the outcome of patients who experience a relapse after such treatment. Patients and Methods Data from 185 patients who relapsed after adjuvant carboplatin between January 1987 and August 2013 at 31 centers/groups from 20 countries were collected and retrospectively analyzed. Primary outcomes were disease-free survival and overall survival. Secondary outcomes were time to, stage at, and treatment of relapse as well as rate of subsequent relapses. Results With a median follow-up of 53 months (95% CI, 48 to 60 months) the 5-year disease-free survival was 82% (95% CI, 77% to 89%), and the 5-year overall survival was 98% (95% CI, 95% to 100%). The median time from orchiectomy to relapse was 19 months (95% CI, 17 to 23 months); 15% (95% CI, 10% to 21%) of relapses occurred > 3 years after treatment. The majority of relapses were detected by computed tomography scan during routine follow-up, 98% in the International Germ Cell Cancer Collaborative Group good prognosis group. Chemotherapy was administered to 92% of patients, mostly as standard first-line treatment corresponding to stage; 8% of patients had additional local treatments. Only 28 patients experienced a second relapse. At last follow-up, 174 (94%) of 185 patients were alive without disease, and four patients with disease. Seven patients died, three of whom due to progressive disease. Conclusion Within the limitations of a retrospective analysis, the results suggest that the majority of patients who experience a relapse after adjuvant carboplatin for clinical stage I seminoma can be successfully treated with a cisplatin-based chemotherapy regimen adequate for stage. Because 15% of the relapses occurred > 3 years after adjuvant treatment, a minimum of 5 years follow-up is recommended.
Papulovesicular Eruption in a Pregnant Woman With Darier Disease
Authors: Carolyn Stull, Niraj Butala, Warren R. Heymann
Journal: JAMA Dermatology (2016)

A primigravida woman with a history of Darier disease had an acute, painful eruption on her face and neck, and physical examination revealed confluent erythema with keratotic papulovesicles distributed on the face and neck. What is your diagnosis?
Bortezomib Does Not Increase Thromboembolic Risk in Multiple Myeloma and May Offer a Protective Effect with Thalidomide/Lenalidomide-Based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens.
Authors: Maurizio Zangari, Louis M. Fink, Fenghuang Zhan, Guido J. Tricot
Journal: Blood (2009)
In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.
Authors: Bao-An Chen, Jing-jing Guo, Feng Gao, Chong Gao, Jian Chen, Yun-Yu Sun, Jun Wang, Gang Zhao, Jia-Hua Ding, Ning-Na Chen, Xiao-Ping Pei, Yong-Yuan Dai, Qian Shun
Journal: Blood (2007)
Update On Imatinib-Resistant Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) On Nilotinib Therapy at 24 Months: Clinical Response, Safety, and Long-Term Outcomes.
Authors: Hagop M. Kantarjian, Francis J. Giles, Kapil N. Bhalla, Javier Pinilla-Ibarz, Richard A. Larson, Norbert Gattermann, Oliver G. Ottmann, Andreas Hochhaus, Jerald P. Radich, Giuseppe Saglio, Timothy P. Hughes, Giovanni Martinelli, Dong-Wook Kim, Yaping Shou, Neil J. Gallagher, Jim Wang, Jorge Cortes-Franco, Michele Baccarani, Philipp D. le Coutre
Journal: Blood (2009)
Evaluation of ZAP-70 Expression Using Real-Time Quantitative RT-PCR (RQ-PCR) in Chronic Lymphocytic Leukemia (CLL), a Reference Method for Flow Cytometry (FCM) Harmonization?.
Authors: Remi Letestu, Fanny Baran-Marszak, Valerie Lefebvre, Celine Salmon, Pierre-Antoine Deglesne, Isabelle Clavereau, Claudine Roger, Florence Ajchenbaum-Cymbalista
Journal: Blood (2005)
SURG-21HISTOPATHOLOGICAL MEANING OF 5-AMINOLEVULINIC ACID-DERIVED FLUORESCENCE ON THE VENTRICLE WALL WITHOUT INVOLVEMENT OF TUMOR ON MAGNETIC RESONANCE IMAGES
Authors: Ju Hyung Moon, Tae Hoon Roh, Se Hoon Kim, Eui Hyun Kim, Jong Hee Chang, Sun Ho Kim, Seok-Gu Kang
Journal: Neuro-Oncology (2015)
High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)
Authors: Aleksandra Butrym, Dagmara Baczynska, Andrzej Tukiendorf, Justyna Rybka, Tadeusz Dobosz, Wojciech Jurczak, Kazimierz Kuliczkowski, Grzegorz Mazur
Journal: Blood (2014)
High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated with Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS)
Authors: Alfonso Quintás-Cardama, Ross Levine, Taghi Manshouri, Outi Kilpivaara, Hagop M. Kantarjian, Srdan Verstovsek
Journal: Blood (2010)
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Authors: Matteo Marchesini, Paola Storti, Yamini Ogoti, Marianna D'Anca, Luigi Nezi, Yue Wei, Hui Yang, Derrick Ong, Antonino Neri, Nicola Giuliani, Guillermo Garcia-Manero, Ronald DePinho, Simona Colla
Journal: Blood (2014)
Risk of Progression and Survival in Newly Diagnosed Multiple Myeloma Patients Non-Responsive to Bortezomib-Based Induction Therapy: an Observational Multicenter International Study
Authors: Yael C Cohen, Erel Joffe, Noam Benyamini, Meletios A. Dimopoulos, Svetlana Trestman, Viki Held, Irit Avivi, Efstathios Kastritis
Journal: Blood (2014)
Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma
Authors: Aparna Sundaram, Chun Chen, Amin Khalifeh-Soltani, Amha Atakilit, Xin Ren, Wenli Qiu, Hyunil Jo, William DeGrado, Xiaozhu Huang, Dean Sheppard
Journal: Journal of Clinical Investigation (2016)

Treatment options are limited for severe asthma, and the need for additional therapies remains great. Previously, we demonstrated that integrin αvβ6-deficient mice are protected from airway hyperresponsiveness, due in part to increased expression of the murine ortholog of human chymase. Here, we determined that chymase protects against cytokine-enhanced bronchoconstriction by cleaving fibronectin to impair tension transmission in airway smooth muscle (ASM). Additionally, we identified a pathway that can be therapeutically targeted to mitigate the effects of airway hyperresponsiveness. Administration of chymase to human bronchial rings abrogated IL-13-enhanced contraction, and this effect was not due to alterations in calcium homeostasis or myosin light chain phosphorylation. Rather, chymase cleaved fibronectin, inhibited ASM adhesion, and attenuated focal adhesion phosphorylation. Disruption of integrin ligation with an RGD-containing peptide abrogated IL-13-enhanced contraction, with no further effect from chymase. We identified α5β1 as the primary fibronectin-binding integrin in ASM, and α5β1-specific blockade inhibited focal adhesion phosphorylation and IL-13-enhanced contraction, with no additional effect from chymase. Delivery of an α5β1 inhibitor into murine airways abrogated the exaggerated bronchoconstriction induced by allergen sensitization and challenge. Finally, α5β1 blockade enhanced the effect of the bronchodilator isoproterenol on airway relaxation. Our data identify the α5β1 integrin as a potential therapeutic target to mitigate the severity of airway contraction in asthma.
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing High Dose Therapy Followed By Autologous Stem Cell Transplant
Authors: Lakshminarayanan Nandagopal, J. Christine Ye, Marie Ventimiglia, Muneer H. Abidi, Lois Ayash, Jeffrey Zonder, Lawrence G Lum, Joseph P. Uberti, Voravit Ratanatharathorn, Divaya Bhutani, Abhinav Deol
Journal: Blood (2014)
Cytogenetic Abnormalities in B-CLL at Binet Stage A: Overview in a Cohort of 484 Untreated Patients and Relations with the ZAP-70 and IgVH Mutation Status.
Authors: Florence Nguyen-Khac, E. Callet Bauchu, C. Bastard, C. Lefebvre, S. Ramond, F. Mugneret, V. Eclache, E. Bergoin, M. Lafage-Pochilatoff, D. Naghib, B. Quilichini, C. Barin, F. Davi, H. Merle-Beral, S. Dominique Raynaud
Journal: Blood (2005)
Acute Myeloid Leukemia in the Elderly Is Characterized By a Distinct Genetic Landscape
Authors: Patricia Silva, Martin Neumann, Sebastian Vosberg, Cornelia Schlee, Konstandina Isaakidis, Michael P Schroeder, Jutta Ortiz-Tánchez, Lars R. Fransecky, Teresa Hartung, Alexander Graf, Stefan Krebs, Helmut Blum, Gerhard Ehninger, Hubert Serve, Wolfgang E Berdel, Philipp A. Greif, Christoph Röllig, Claudia D Baldus
Journal: Blood (2015)
Epigenetic Targeting Via Transcriptional Inhibition of DNA Methyltransferase: a Phase I Study of Bortezomib in Combination with 5-Azacytidine in Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML).
Authors: William Blum, Rebecca B. Klisovic, Alison Walker, Ramiro Garzon, Shujun Liu, Larry J. Schaaf, Kristina Humphries, Michael R. Grever, Steven M. Devine, John C. Byrd, Guido Marcucci
Journal: Blood (2009)
Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry
Authors: Ivan Spasojevic, Ligia R. S. da Costa, Mitchell E. Horwitz, Gwynn D. Long, Keith M. Sullivan, John P. Chute, Cristina Gasparetto, Ashley Morris, Nelson J. Chao, David A. Rizzieri
Journal: Blood (2011)
A Broader Understanding of Moral Distress
Authors: Stephen M. Campbell, Connie M. Ulrich, Christine Grady
Journal: The American Journal of Bioethics (2016)

On the traditional view, moral distress arises only in cases where an individual believes she knows the morally right thing to do but fails to perform that action due to various constraints. We seek to motivate a broader understanding of moral distress. We begin by presenting six types of distress that fall outside the bounds of the traditional definition and explaining why they should be recognized as forms of moral distress. We then propose and defend a new and more expansive definition of moral distress and examine how it can enable the development of a taxonomy of moral distress.
Allogeneic Stem Cell Transplantation of Mantle Cell Lymphoma - Results of the Prodpective Trials OSHO #060 and OSHO #074
Authors: William H Krüger, Carsten Hirt, Nadezda Basara, Dietger Niederwieser, Gerhard Behre, Norbert Grobe, Herbert G. Sayer, Georg Maschmeyer, Thomas Fischer, Michael Kiehl, Christoph Busemann, Gottfried Doelken
Journal: Blood (2011)
Effect of Valproate on In Vitro Steroid Responsiveness in 2-Phase Erythroid Culture in Diamond Blackfan Anemia (DBA): Potential Role for Histone Deacetylation in the Mechanism of Action of Steroids in DBA.
Authors: Yaw Ohene-Abuakwa, Carine Marius, David White, Ball Sarah
Journal: Blood (2006)
Priming of Mir-181a in Acute Myeloid Leukemia (AML) to Increase Chemosensitivity: A Phase I Trial of Lenalidomide (LEN) Followed by Idarubicin and Cytarabine.
Authors: William Blum, Rebecca B Klisovic, Alison Walker, Sebastian Schwind, Yao Jiang, Jiang Wang, Mitch Phelps, Susan Geyer, Steven M. Devine, Kathy Walsh, Sumithira Vasu, John P. Curfman, Larry Schaaf, Celia Garr, Cheryl Kefauver, John C. Byrd, Michael R. Grever, Ramiro Garzon, Guido Marcucci
Journal: Blood (2012)
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein
Authors: Reynaria Pitts, Elise Gunzburger, Christie M. Ballantyne, Philip J. Barter, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Stephen J. Nicholls, Eric J. Niesor, Anders G. Olsson, Prediman K. Shah, Jean-Claude Tardif, John Kittelson, Gregory G. Schwartz
Journal: Journal of the American College of Cardiology (2016)
Psychosocial Factors in Decision-Making of Patient Eligibility for Allogeneic Bone Marrow Transplantation.
Authors: Brian J. Bolwell, Linda McLellan, Elizabeth Kuczkowski, Jane Dabney, Victoria Wentling, Brad Pohlman, Ronald Sobecks, Steven Andresen, Matt Kalaycio, Bridget Rini, Julie Curtis, Larry W. Foster, Mikkael A. Sekeres
Journal: Blood (2004)
Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian™ Trials.
Authors: Elena Santagostino, Steven R. Lentz, Mudi Misgav, Brigitte Brand, Pratima Chowdary, Aleksander Savic, Yurdanur Kilinc, Edward GD Tuddenham, Anders Lindblom
Journal: Blood (2012)
B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma
Authors: Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, James N. Kochenderfer
Journal: Blood (2012)
Selective Targeting of Vascular Endothelial Growth Factor (VEGF) Receptor Signaling with Pazopanib and Vatalanib Induces Apoptosis in Chronic Lymphoctic Leukemia (CLL) Cells in Vitro Inhibits Growth of Human CLL Like Tumor Xenografts in Mice.
Authors: Julian Paesler, Iris Gehrke, Regina Razavi, Rajesh Kumar Gandhirajan, Alexandra Filipovich, Magdalena Hertweck, Felix Erdfelder, Sabrina Uhrmacher, Simon Jonas Poll-Wolbeck, Michael Hallek, Karl Anton Kreuzer
Journal: Blood (2009)
Genomic Landscape of Immunoglobulin Light Chain (AL) Amyloidosis and Comparative Analyses with Related Malignant Plasma Cell Disorder- Multiple Myeloma
Authors: Vishwanathan Hucthagowder, Jahangheer Shaik, Mark Fiala, Jacob Paasch, Rakesh Nagarajan, Keith E. Stockerl-Goldstein, John F. DiPersio, Michael H. Tomasson, Ravi Vij, Shashikant Kulkarni
Journal: Blood (2011)
Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis
Authors: Tobias Petzold, Manuela Thienel, Ildiko Konrad, Irene Schubert, Ron Regenauer, Boj Hoppe, Michael Lorenz, Annekathrin Eckart, Sue Chandraratne, Carsten Lennerz, Christof Kolb, Daniel Braun, Janina Jamasbi, Richard Brandl, Siegmund Braun, Wolfgang Siess, Christian Schulz, Steffen Massberg
Journal: Science Translational Medicine (2016)

Blood treated with an oral thrombin inhibitor demonstrates enhanced thrombus formation under flow conditions in humans and in rodents.
Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)
Authors: David Valcárcel, Vera Adema, Mar Mallo, Margarita Ortega, Benet Nomdedeu, Guillermo Sanz, Elisa Luño, Del CaÃ‘izo Consuelo, Javier De la Serna, Maita Ardanaz, Victor Marco, Rosa Collado, Blanca Xicoy, Francesc Sole, Teresa Vallespi
Journal: Blood (2011)
Parenthood in Long-Term Survivors After CHOEP Treatment for Aggressive Lymphoma Is Not Significantly Impaired in Comparison to the General Population. Results From the Mabthera International Trial (MInT) and the DSHNHL NHLB1 Study
Authors: Julia Meissner, Sascha Dietrich, Marita Ziepert, Evelyn Kuhnt, Tanja Rixecker, Mathias Witzens-Harig, Michael Pfreundschuh, Anthony D Ho
Journal: Blood (2012)
Bisphosphonate Therapy Associated with an Increased Incidence of Mandibular/Maxillary Osteomyelitis in Multiple Myeloma Patients.
Authors: Snehal G. Thakkar, Carlos Isada, Kristin Englund, Walter Tomford, Mary Ann Karam, Janice L. Reed, James Smith, Mohamad A. Hussein
Journal: Blood (2004)
TET2 Downregulation Leads to AML Cells Sensitive to Decitabine
Authors: Qingxiao Chen, Jingsong He, Xing Guo, Jing Chen, Li Yang, Xuanru Lin, Yi Li, Enfan Zhang, Yang Yang, Wenjun Wu, Donghua He, He Huang, Shizhou Liu, Zhen Cai
Journal: Blood (2015)
Expression Levels of Glutathione Peroxidase 1 (GPx1) and Multi-Drug Resistance 1 (MDR1; ABCB1) Identify Patients with Diffuse Large B-Cell Lymphoma (DLBCL) That Have Superior Clinical Outcomes.
Authors: Charalambos Andreadis, Phyllis Gimotty, Rachel Hammond, Peter Wahl, Jane Houldsworth, Stephen Schuster, Timothy Rebbeck
Journal: Blood (2006)
Discovery of SB-497115, a Small-Molecule Thrombopoietin (TPO) Receptor Agonist for the Treatment of Thrombocytopenia.
Authors: Juan I. Luengo, Kevin J. Duffy, Anthony N. Shaw, Evelyne Delorme, Kenneth J. Wiggall, Leslie Giampa, Nannan Liu, Heather Smith, Shin-Shay Tian, Stephen G. Miller, Richard M. Keenan, Jon Rosen, Susan B. Dillon, Peter Lamb, Connie L. Erickson-Miller
Journal: Blood (2004)
Carboxyl Terminal Domains Of ADAMTS13 Inhibit The Formation Of Ultra Large VWF Strings and Platelet/Leukocyte Aggregates On Endothelial Cells In Murine Mesenteric Venules Via a Disulfide Bond Reduction Mechanism
Authors: Jialing Bao, Yingying Mao, X. Long Zheng
Journal: Blood (2013)
Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.
Authors: Masood A. Shammas, Hemanta Koley, Ramesh B. Batchu, Paola Neri, Pierfrancesco Tassone, Rao Prabhala, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Blood (2004)
Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism
Authors: Shan He, Fang Xie, Qing Tong, Kazuhiro Mochizuki, Yongnian Liu, Philip E Lapinski, Shin Mineishi, Ram Shankar Mani, Victor E Marquez, Arul M. Chinnaiyan, Philip D King, Yi Zhang
Journal: Blood (2012)
Minicircle Plasmid Containing the Human Manganese Superoxide Dismutase (MnSOD) Transgene Confers Radioprotection to Hematopoietic Progenitor Cell Line 32Dcl3.
Authors: Xichen Zhang, Michael W. Epperly, Mark A. Kay, Zhi-Ying Chen, Tracy Smith, Darcy Franicola, Benjamin Greenberger, Paavani Komanduri, Joel S. Greenberger
Journal: Blood (2007)
Nanocomposite Hydrogels and Their Applications in Tissue Engineering
Authors: Andisheh Motealleh, Nermin Seda Kehr
Journal: Advanced Healthcare Materials (2016)

Nanocomposite (NC) hydrogels, organic–inorganic hybrid materials, are of great interest as artificial three‐dimensional (3D) biomaterials for biomedical applications. NC hydrogels are prepared in water by chemically or physically cross‐linking organic polymers with nanomaterials (NMs). The incorporation of hard inorganic NMs into the soft organic polymer matrix enhances the physical, chemical, and biological properties of NC hydrogels. Therefore, NC hydrogels are excellent candidates for artificial 3D biomaterials, particularly in tissue engineering applications, where they can mimic the chemical, mechanical, electrical, and biological properties of native tissues. A wide range of functional NMs and synthetic or natural organic polymers have been used to design new NC hydrogels with novel properties and tailored functionalities for biomedical uses. Each of these approaches can improve the development of NC hydrogels and, thus, provide advanced 3D biomaterials for biomedical applications.
Reciprocal Crosstalk Between Autophagic and Endocrine Signaling in Metabolic Homeostasis
Authors: Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen
Journal: Endocrine Reviews (2016)

Abstract Autophagy is a cellular quality control and energy-providing process that is under strict control by intra- and extracellular stimuli. Recently, there has been an exponential increase in autophagy research and its implications for mammalian physiology. Autophagy deregulation is now being implicated in many human diseases, and its modulation has shown promising results in several preclinical studies. However, despite the initial discovery of autophagy as a hormone-regulated process by De Duve in the early 1960s, endocrine regulation of autophagy still remains poorly understood. In this review, we provide a critical summary of our present understanding of the basic mechanism of autophagy, its regulation by endocrine hormones, and its contribution to endocrine and metabolic homeostasis under physiological and pathological settings. Understanding the cross-regulation of hormones and autophagy on endocrine cell signaling and function will provide new insight into mammalian physiology as well as promote the development of new therapeutic strategies involving modulation of autophagy in endocrine and metabolic disorders.
High Avidity PRAME Specific T Cells Derived From In Vivo HLA Mismatched Transplantation Setting Potentially Useful for Immunotherapeutic Strategies.
Authors: Avital L. Amir, Dirk M. van der Steen, Renate S. Hagedoorn, Marieke Griffioen, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Journal: Blood (2009)
Phase II Clinical Trial Results of Dasatinib for Frontline Therapy in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
Authors: Naveen Pemmaraju, Hagop M. Kantarjian, Susan O'Brien, Gautam Borthakur, Farhad Ravandi, Srdan Verstovsek, Naval G. Daver, Guillermo Garcia-Manero, Courtney D. DiNardo, Jeff Skinner, Marina Konopleva, Sherry Pierce, Elias Jabbour, Jorge E. Cortes
Journal: Blood (2014)
Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) a Phase I/II Trial in Advanced Relapsed/Refractory Multiple Myeloma (RMM) Patients.
Authors: Mohamad A. Hussein, Mary Ann Karam, Catherine Brand, Greg L. Pearce, Janice Reed, Kellie Bruening, Paul Sartori, Gordan Srkalovic, Marta Olesnyckyj, Robert Knight, Kathe Balinski, Jerome Zeldis
Journal: Blood (2004)
Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo.
Authors: Tarun K. Garg, Susann Szmania, Paul Malbrough, Charles Ekworomadu, Katie Stone, Amberly Moreno-Bost, Emily Woods, Jumei Shi, Shmuel Yaccoby, John D Shaughnessy, Bart Barlogie, Dario Campana, Frits van Rhee
Journal: Blood (2009)
A Pilot Trial of Imatinib, Low-Dose Cytarabine (ara-C) and Idarubicin (Ida) in Patients (pts) with Chronic Myeloid Leukemia (CML) in Myeloid Blastic Phase (BP).
Authors: Alfonso Quintas-Cardama, Hagop Kantarjian, Farhad Ravandi, Guillermo Garcia-Manero, Susan O’Brien, William Wierda, Stefan Faderl, Jorge Cortes
Journal: Blood (2005)
Effects of Adaphostin, a Novel Tyrphostin Inhibitor, in Diverse Models of Imatinib Mesylate Resistance.
Authors: Joya Chandra, Jeannette Tracy, Mercedes Gorre, Moshe Talpaz, James Griffin, Srdan Verstovsek, Miloslav Beran, Charles Sawyers, Edward Sausville, Scott Kaufmann
Journal: Blood (2004)
Gistic Evaluation in Sezary Syndrome
Authors: Cristina Cristofoletti, Valeria Tocco, Maria Grazia Narducci, Enrico Scala, Emilio Berti, Marina Frontani, Giuseppe Alfonso Lombardo, Alessandro Monopoli, Mauro Helmer Citterich, Antonella Bresin, Maria Cristina Picchio, Giandomenico Russo, Elisabetta Caprini
Journal: Blood (2012)
Immunological Profile of Patients after HSCT Using the FCC Conditioning Regimen for Treatment of Severe Aplastic Anemia Shows Sustained Mixed T-Cell Chimerism Is Due to Persistence of Recipient CD8 T Cells and Indicates Potential Basis for Tolerance and Extremely Low Incidence of Graft Versus Host Disease
Authors: Francesco Grimaldi, Pilar Perez-Abellan, Steven Best, Nicholas Lea, John Veluchamy, Muhammad Atif, Rosemary Grain, Monica Sen, Austin G. Kulasekararaj, Antonio Pagliuca, Victoria T Potter, Ghulam J Mufti, Judith C.W. Marsh, Linda D Barber
Journal: Blood (2015)